Notice is hereby given that the Office of Research Integrity (ORI) has made a final finding of scientific misconduct in the following case: Melissa A. Harrington, University of Texas Southwestern Medical Center: Based upon an investigation conducted by the University of Texas Southwestern Medical Center, information obtained by ORI during its oversight review, and Dr. Harrington\'s own admission, ORI found that Melissa A. Harrington, Ph.D., former postdoctoral research fellow, Department of Pharmacology at the University of Texas Southwestern Medical Center, engaged in scientific misconduct by falsifying the methodology and figures in a manuscript that was accepted for publication in the Journal of Neuroscience (\`\`Gα\<INF\>q and Gβ\<INF\>y open two Bradykinin-gated potassium channels via a membrane-delimited pathway\'\'). The research was supported by a grant from the National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH). Specifically, ORI found that Dr. Harrington had (1) falsely described the addition of GDP to a G-protein subunit buffer, when she had omitted it from some of the experiments; (2) falsified three figures (a) by falsely depicting the course of an electrophysiological response as being due to a combination of two substances that had not been combined and (b) by falsely representing a single channel current record as being an example of a distinct channel type that was elicited by the substance Gα\<INF\>q, which had not been added prior to the recording; and (3) intentionally incorporated the falsified data from the experiments in which GDP had been omitted into her statistical descriptions. The Journal of Neuroscience manuscript was withdrawn and was never published. Dr. Harrington has accepted the ORI finding and has entered into a Voluntary Exclusion Agreement with ORI in which she has voluntarily agreed, for the three (3) year period beginning October 23, 1996: (1) To voluntarily exclude herself from serving in any advisory capacity to the Public Health Service (PHS), including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant; and (2) That any institution that submits an application for PHS support for a research project on which the respondent\'s participation is proposed or which uses the respondent in any capacity on PHS supported research must concurrently submit a plan for supervision of her duties. The supervisory plan must be designed to ensure the scientific integrity of the respondent\'s research contribution. The institution must submit a copy of the supervisory plan to ORI.
